Understanding glioma stem cells: rationale, clinical relevance and therapeutic strategies

Atique U Ahmed1, Brenda Auffinger, Maciej S Lesniak

  • 1The Brain Tumor Center, The University of Chicago, Chicago, IL 60637, USA.

Insights

Glioma stem cells (GSCs) contribute to aggressive brain tumor recurrence and resistance to therapy. Targeting these cells offers new hope for improving glioblastoma patient survival.

Area of Science:

  • Neuro-oncology
  • Cancer Stem Cell Biology

Background:

  • Glioblastoma multiforme is an aggressive adult brain tumor with a poor prognosis.
  • Multimodal therapies offer limited long-term success.
  • The discovery of glioma stem cells (GSCs) offers potential explanations for tumor heterogeneity and treatment resistance.

Purpose of the Study:

  • To discuss the role of GSCs in glioma relapse.
  • To explore controversies surrounding GSC research.
  • To review novel therapeutic strategies targeting GSCs.

Main Methods:

  • Literature review of GSC mechanisms.
  • Analysis of GSC heterogeneity.
  • Discussion of emerging therapeutic approaches.

Main Results:

  • GSCs are implicated in glioblastoma recurrence and resistance to chemotherapy and radiotherapy.
  • Significant variability exists in GSC phenotypes among patients and within tumors.
  • Targeting GSCs is crucial for reducing tumor recurrence and enhancing patient survival.

Conclusions:

  • GSC research, though evolving, provides critical insights into glioblastoma biology.
  • Understanding GSC mechanisms is key to developing more effective treatments.
  • Novel therapies targeting GSCs hold promise for improving outcomes in glioblastoma patients.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...